Cystic fibrosis-related liver disease in children- A vascular or a biliary disease?

Amit Saha1, Michael Stormon2, Peter Lewindon3

  • 1The Royal Children's Hospital, Melbourne, Australia; St John of God Midland Public Hospital, Perth, Australia; Curtin Medical School, Faculty of Health Sciences, Curtin University, Australia.

Insights

Cystic fibrosis-related liver disease (CFLD) predominantly shows biliary cirrhosis, with non-cirrhotic portal hypertension (NCPH) appearing as focal, possibly early, features. This study analyzed pediatric liver transplant cases to understand CFLD pathophysiology.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Transplant Surgery

Background:

  • Cystic fibrosis-related liver disease (CFLD) was traditionally attributed to CFTR dysfunction leading to biliary complications and cirrhosis.
  • Non-cirrhotic portal hypertension (NCPH) has emerged as a potential alternative mechanism in CFLD pathogenesis.

Purpose of the Study:

  • To investigate the histopathological features of CFLD in pediatric liver transplant recipients.
  • To evaluate the prevalence and characteristics of NCPH in conjunction with biliary pathology in CFLD.

Main Methods:

  • Retrospective analysis of clinical data from 18 pediatric CFLD patients undergoing liver transplant in Australia.
  • Independent histopathological review of explanted liver tissues by experienced pathologists.

Main Results:

  • The largest pediatric series reported, with a median age of 13 years; all patients exhibited signs of portal hypertension pre-transplant.
  • Biliary cholestasis/cirrhosis was the predominant histopathological finding in explanted livers.
  • Focal NCPH was observed in 61% of explants, often in less fibrous or macronodular areas.

Conclusions:

  • Biliary fibrosis/cirrhosis remains the primary pathology in CFLD.
  • NCPH, when present, is typically focal and may represent an early stage of CFLD preceding biliary stasis and cirrhosis.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
722
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
476
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
214
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
697